10x Genomics (TXG) Inventory (2018 - 2026)

10x Genomics has disclosed Inventory across 9 years of filings, most recently posting $53.5 million for Q1 2026.

• Inventory for Q1 2026 came in at $53.5 million, down 28.41% year-over-year; the trailing twelve-month figure through Mar 2026 was $53.5 million (down 28.41% YoY), and the FY2025 annual result was $56.3 million, down 32.21% from the prior year.
• Inventory came in at $53.5 million for Q1 2026 at 10x Genomics, down from $56.3 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $94.0 million in Q3 2024 to a low of $53.5 million in Q1 2026.
• The 5-year median for Inventory is $78.6 million (2022), against an average of $75.3 million.
• Across the five-year window, Inventory soared 65.42% in 2022 and plunged 34.12% in 2025, its largest moves.
• 10x Genomics' Inventory stood at $81.6 million in 2022, then dropped by 9.71% to $73.7 million in 2023, then grew by 12.75% to $83.1 million in 2024, then sank by 32.21% to $56.3 million in 2025, then decreased by 5.07% to $53.5 million in 2026.
• The last three Inventory figures came in at $53.5 million (Q1 2026), $56.3 million (Q4 2025), and $62.0 million (Q3 2025), per Business Quant data.